Prof. Dr. Rolf Marschalek

Publikationsliste - Publication list

siehe auchPubMed

2013

Oh SJ, Park TS, Lee JY, Mun YC, Seong CM, Marschalek R, Meyer C, Chung WS, Huh J (2013). Acute Promyelocytic Leukemia with a Rare PML Exon 4/ RARA Exon 3 Fusion Transcript Variant. Acta Haematol 130, 176-180.

Yang JJ, Oh SH, Meyer C, Marschalek R, Park TS (2013). RE: Acute myeloid leukemia associated with FGFR1 abnormalities. Int J Hematol 2013 Jun 7. [Epub ahead of print].

Tuborgh A, Meyer C, Marschalek R, Preiss B, Hasle H, Kjeldsen E (2013). Complex Three-Way Translocation Involving MLL , ELL , RREB1 , and CMAHP Genes in an Infant with Acute Myeloid Leukemia and t(6;19;11)(p22.2;p13.1;q23.3). Cytogenet Genome Res 2013 May 30. [Epub ahead of print].

Launay E, Henry C, Meyer C, Chappé C, Taque S, Boulland ML, Abdelali RB, Dugay F, Marschalek R, Bastard C, Fest T, Gandemer V, Belaud-Rotureau MA (2013). MLL-SEPT5 Fusion Transcript in Infant Acute Myeloid Leukemia with t(11;22)(q23;q11). Leuk Lymphoma 2013 Jun 3. [Epub ahead of print].

Meyer C, Zur Stadt U, Escherich G, Hofmann J, Binato R, Barbosa Tda C, Emerenciano M, Pombo-de-Oliveira MS, Horstmann M, Marschalek R (2013). Refinement of IKZF1 recombination hotspots in pediatric BCP-ALL patients. Am J Blood Res 3, 165-173.

Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M, Pombo de Oliveira M, Renneville A, Villarese P, Macintyre E, Cavé H, Clappier E, Mass-Malo K, Zuna J, Trka J, De Braekeleer E, De Braekeleer M, Oh SH, Tsaur G, Fechina L, van der Velden VH, van Dongen JJ, Delabesse E, Binato R, Silva ML, Kustanovich A, Aleinikova O, Harris MH, Lund-Aho T, Juvonen V, Heidenreich O, Vormoor J, Choi WW, Jarosova M, Kolenova A, Bueno C, Menendez P, Wehner S, Eckert C, Talmant P, Tondeur S, Lippert E, Launay E, Henry C, Ballerini P, Lapillone H, Callanan MB, Cayuela JM, Herbaux C, Cazzaniga G, Kakadiya PM, Bohlander S, Ahlmann M, Choi JR, Gameiro P, Lee DS, Krauter J, Cornillet-Lefebvre P, Te Kronnie G, Schäfer BW, Kubetzko S, Alonso CN, Zur Stadt U, Sutton R, Venn NC, Izraeli S, Trakhtenbrot L, Madsen HO, Archer P, Hancock J, Cerveira N, Teixeira MR, Lo Nigro L, Möricke A, Stanulla M, Schrappe M, Sedék L, Szczepanski T, Zwaan CM, Coenen EA, van den Heuvel-Eibrink MM, Strehl S, Dworzak M, Panzer-Grümayer R, Dingermann T, Klingebiel T, Marschalek R (2013). The MLL recombinome of acute leukemias in 2013. Leukemia 2013 Apr 30. doi: 10.1038/leu.2013.135. [Epub ahead of print].

Buscató El, Büttner D, Brüggerhoff A, Klingler FM, Weber J, Scholz B, Zivković A, Marschalek R, Stark H, Steinhilber D, Bode HB, Proschak E (2013). From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties. ChemMedChem 8, 919-923.

Binato R, Meyer C, Macedo-Silva ML, Garcia D, Figueiredo A, Hofmann J, Vieira TP, Abdelhay E, Marschalek R (2013). Analyzing acute leukemia patients with complex MLL rearrangements by a sequential LDI-PCR approach. Cancer Lett 2013 Apr 2. doi:pii: S0304-3835(13)00271-1. 10.1016/j.canlet.2013.03.029. [Epub ahead of print].

Emerenciano M, Meyer C, Mansur MB, Marschalek R, Pombo-de-Oliveira MS; Brazilian Collaborative Study Group of Infant Acute Leukaemia. The distribution of MLL breakpoints correlates with outcome in infant acute leukaemia. Br J Haematol 161, 224-236.

Emerenciano M, Kowarz E, Karl K, de Almeida Lopes B, Scholz B, Bracharz S, Meyer C, Pombo-de-Oliveira MS, Marschalek R (2013). Functional analysis of the two reciprocal fusion genes MLL-NEBL and NEBL-MLL reveal their oncogenic potential. Cancer Lett 332, 30-34.

Prelle C, Bursen A, Dingermann T, Marschalek R (2013). Secondary mutations in t(4;11) leukemia patients. Leukemia 27, 1425-1427.

2012

Kim MJ, Yang JJ, Meyer C, Marschalek R, Park TS (2012). Molecular methods for genomic analyses of variant PML-RARA or other RARA-related chromosomal translocations in acute promyelocytic leukemia. Korean J Hematol 47, 307-308.

Burmeister T, Molkentin M, Meyer C, Lachmann N, Schwartz S, Friedrichs B, Beyer J, Blau IW, Lohm G, Tietze-Bürger C, Marschalek R, Uharek L (2012). Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse. Exp Hematol Oncol 1, 6.

Kowarz E, Dingermann T, Marschalek R (2012). Do Non-Genomically Encoded Fusion Transcripts Cause Recurrent Chromosomal Translocations? Cancers 4, 1036-1049. NOT LISTED IN PUBMED

Lee SG, Cho SY, Kim MJ, Oh SH, Cho EH, Lee S, Baek EJ, Choi JH, Bohlander SK, Lode L, Richebourg S, Yoon HJ, Marschalek R, Meyer C, Park TS (2012). Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias. Haematologica 2012 Oct 25. [Epub ahead of print]

Coenen EA, Driessen EM, Zwaan CM, Stary J, Baruchel A, de Haas V, de Bont ES, Reinhardt D, Kaspers GJ, Arentsen-Peters ST, Meyer C, Marschalek R, Pieters R, Stam RW, van den Heuvel-Eibrink MM (2012). CBL mutations do not frequently occur in paediatric acute myeloid leukaemia. Br J Haematol 159, 577-584.

Türkmen S, Timmermann B, Bartels G, Gröger D, Meyer C, Schwartz S, Haferlach C, Rieder H, Gökbuget N, Hoelzer D, Marschalek R, Burmeister T (2012). Involvement of the MLL gene in adult T-lymphoblastic leukemia. Genes Chrom Cancer 51, 1114-1124.

Lee SG, Park TS, Yang JJ, Oh SH, Cho EH, Lee S, Oh D, Huh JY, Marschalek R, Meyer C (2012). Molecular identification of a new splicing variant of the MLL - MLLT11 fusion transcript in an adult with acute myeloid leukemia and t(1;11)(q21;q23). Acta Haematol 128, 131-138.

Cerveira N, Lisboa S, Correia C, Bizarro S, Santos J, Torres L, Vieira J, Barros-Silva JD, Pereira D, Moreira C, Meyer C, Oliva T, Moreira I, Martins Â, Viterbo L, Costa V, Marschalek R, Pinto A, Mariz JM, Teixeira MR (2012). Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution. Mol Oncol 6, 553-564.

Marschalek R (2012). [Translocations of the MLL gene: New insights into high-risk leukemia]. PharmUZ 41, 196-200.

Marschalek R (2012). [Genetic basis of leukemia: Serious consequences of chromosomal translocations]. PharmUZ 41, 190-195.

Marschalek R, Zündorf I, Dingermann T (2012). [Leukemia: A highly malignant disease]. PharmUZ 41, 186-189.

Yang JJ, Marschalek R, Meyer C, Park TS (2012). Diagnostic usefulness of genomic breakpoint analysis of various gene rearrangements in acute leukemias: a perspective of long distance- or long distance inverse-PCR-based approaches. Ann Lab Med 32, 316-318.

Scholz B, Marschalek R (2012). Epigenetics and blood disorders. Br J Haematol 158, 307-322.

Ussowicz M, Jaśkowiec A, Meyer C, Marschalek R, Chybicka A, Szczepański T, Haus O (2012). A three-way translocation of MLL, MLLT11, and the novel reciprocal partner gene MYO18A in a child with acute myeloid leukemia. Cancer Genet 205, 261-265.

Park TS, Jeon YL, Lee HJ, Jeong JH, Kim SY, Cho EH, Marschalek R, Meyer C (2012). Detection of EML4-ALK and other ALK fusion genes in lung cancer: a lesson from the leukemia fusion gene analysis and future application. J Korean Med Sci 27, 576-577.

Marschalek R, Dingermann T (2012. [Pharmazie in unserer Zeit 3/2012]. Pharm Unserer Zeit. 2012 May;41(3):179.

Yang JJ, Park TS, Kim MJ, Cho EH, Oh SH, Jeon BR, Oh D, Huh JY, Marschalek R, Meyer C. Acute promyelocytic leukemia with trisomy 8 showing normal PML-RARA FISH signal patterns: diagnostic application of long-distance polymerase chain reaction in molecularly discrepant leukemia cases. Ann Hematol 91, 1645-1648.

Coenen EA, Zwaan CM, Meyer C, Marschalek R, Creutzig U, Pieters R, Bradtke J, van den Heuvel-Eibrink MM (2012). Abl-interactor 2 (ABI2): A novel MLL translocation partner in acute myeloid leukemia. Leuk Res 36, e113-5.

Yang JJ, Park TS, Choi JR, Park SJ, Cho SY, Jun KR, Kim HR, Lee JN, Oh SH, Lee S, Kim B, Marschalek R, Meyer C (2012). Submicroscopic Deletion of FGFR1 Gene Is Recurrently Detected in Myeloid and Lymphoid Neoplasms Associated with ZMYM2-FGFR1 Rearrangements: A Case Study. Acta Haematol 127, 119-123.

Hartmann D, Lucks J, Fuchs S, Schiffmann S, Schreiber Y, Ferreirós N, Merkens J, Marschalek R, Geisslinger G, Grösch S (2012). Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth. Int J Biochem Cell Biol 44, 620-628.

de Braekeleer E, Douet-Guilbert N, Meyer C, van Deventer FM, Marschalek R, de Braekeleer M (2012). MLL-ELL fusion gene in two infants with acute monoblastic leukemia and myeloid sarcoma. Leuk Lymphoma 53, 1222-1224.

Cho SY, Park TS, Oh SH, Cho EH, Oh D, Huh JY, Marschalek R, Meyer C (2012). Genomic analysis of a four-way t(4;11;22;10) associated with MLL-AF4 in an adult acute lymphoblastic leukemia. Ann Hematol 91, 977-979.

Herbaux C, Poulain S, Meyer C, Marschalek R, Renneville A, Fernandes J, Theisen O, Tricot S, Simon M, Duthilleul P, Daudignon A (2012). TOP3A, a new partner gene fused to MLL in an adult patient with de novo acute myeloid leukaemia. Br J Haematol. 157, 128-131.

2011

Meyer C, Kowarz E, Yip SF, Wan TS, Chan TK, Dingermann T, Chan LC, Marschalek R (2011). A complex MLL rearrangement identified five years after initial MDS diagnosis results in out-of-frame fusions without progression to acute leukemia. Cancer Genet 204, 557-562.

De Braekeleer E, Meyer C, Douet-Guilbert N, Basinko A, Le Bris MJ, Morel F, Berthou C, Marschalek R, Férec C, De Braekeleer M (2011). Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory. Mol Oncol [Epub ahead of print].

Lee SG, Park TS, Oh SH, Park JC, Yang YJ, Marschalek R, Meyer C, Cho EH, Shin SY (2011). De novo Acute Myeloid Leukemia Associated with t(11;17)(q23;q25) and MLL-SEPT9 Rearrangement in an Elderly Patient: A Case Study and Review of the Literature. Acta Haematol 126, 195-198.

Knauer SK, Fetz V, Rabenstein J, Friedl S, Hofmann B, Sabiani S, Schröder E, Kunst L, Proschak E, Thines E, Kindler T, Schneider G, Marschalek R, Stauber RH, Bier C (2011). Bioassays to Monitor Taspase1 Function for the Identification of Pharmacogenetic Inhibitors. PloS One 6, e18253.

Kühlein HN, Tegeder I, Möser C, Lim HY, Häussler A, Spieth K, Jennes I, Marschalek R, Beckhaus T, Karas M, Fauth M, Ehnert C, Geisslinger G, Niederberger E (2011). Nerve injury evoked loss of latexin expression in spinal cord neurons contributes to the development of neuropathic pain. PLoS One 6, e19270.

Lim G, Cho EH, Cho SY, Shin SY, Park JC, Yang YJ, Oh SH, Marschalek R, Meyer C, Park TS (2011). A novel PML-ADAMTS17-RARA gene rearrangement in a patient with pregnancy-related acute promyelocytic leukemia. Leuk Res 35, e106-110.

Emerenciano M, Meyer C, Mecado-Silva ML, de Meis E, Dobbin JA, Marschalek R, Pombo-de-Oliveira MS (2011). Backtracking to birth of the NUP98-HOXD13 gene fusion in an infant acute myeloid leukemia. Leukemia 25, 1192-1194.

Cin H, Meyer C, Herr R, Janzarik WG, Lambert S, Jones DT, Jacob K, Benner A, Witt H, Remke M, Bender S, Falkenstein F, Van Anh TN, Olbrich H, von Deimling A, Pekrun A, Kulozik AE, Gnekow A, Scheurlen W, Witt O, Omran H, Jabado N, Collins VP, Brummer T, Marschalek R, Lichter P, Korshunov A, Pfister SM (2011). Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma. Acta Neuropathol 121, 763-774.

Pless B, Oehm C, Knauer S, Stauber RH, Dingermann T, Marschalek R (2011). The heterodimerization domains of MLL - FYRN and FYRC - are potential target structures in t(4;11) leukemia. Leukemia 25, 663-670.

Kuster L, Kaindl U, Fuka G, Krapf G, Inthal A, Mann G, Kauer M, Rainer J,  Kofler R, Hall A, Metzler M, Meyer C, Harbott J, Marschalek R, Strehl S, Haas OA, Panzer-Grümayer R (2011). ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling. Blood 117, 2658-2667.

Kowarz E, Merkens J, Karas M, Dingermann T, Marschalek R (2011). Premature transcript termination, transsplicing and DNA repair: a viscious path to cancer? Am J Blood Res 1, 1-12.

Zaliova M, Meyer C, Cario G, Marschalek R, Stary J, Zuna J, Trka R (2011). TEL/AML1-positive patients lacking TEL exon 5 resemble canonical TEL/AML1 cases. Pediatr Blood Cancer 56, 217-225.

Bielorai B, Meyer C, Trakhtenbrot L, Izraeli S, Marschalek R, Toren A (2011). Therapy-related acute myeloid leukemia with translocation (2;11)(q37;q23) after treatment for osteosarcoma. Cancer Genet Cytogenet 203, 288-291.

Kim MJ, Choa SY, Kima MH, Leeb JJ, So Young Kanga SY,Choc EH, Huhd J, Yoone HJ, Parka TS, Leea WI, Marschalek R, Meyer C (2011). FISH-negative cryptic PML-RARA rearrangement detected by long distance-polymerase chain reaction and sequencing analyses: A case study and review of the literature. Cancer Genet Cytogenet 203, 278-283.

Marschalek R (2011). Mechanisms of leukemogenesis by MLL fusion proteins. Br J Haematol 152, 141-154.

Roth L, Marschalek R, Oldenburg J, Oyen F, Schneppenheim R (2011). Characterization of two novel large F8 deletions in patients with severe Haemophilia A and FVIII inhibitors. J Thromb Haemost 105, 279-284.

Bier C, Knauer SK, Klapthor A, Schweitzer A, Rekik A, Kraemer OH, Marschalek R, Stauber RH (2011). Cell-based analysis of structure-function activity of Threonine Aspartase 1. J Biol Chem 286, 3007-3017.

Marschalek R (2011). It takes two-to-leukemia: about addictions and requirements. Leuk Res 35, 424-425.

Kuipers JE, Coenen EA, Balgobind BV, Stary J, Baruchel A, de Haas V, de Bont ES, Reinhardt D, Kaspers GJ, Cloos J, Danen-van Oorschot AA, den Boer ML, Marschalek R, Meyer C, Pieters R, Zwaan CM, van den Heuvel-Eibrink MM (2011). High IGSF4 expression in pediatric AML M5 with t(9;11). Blood 117, 928-935.

Benedikt A, Baltruschat S, Scholz B, Bursen A, Arrey TN, Meyer B, Varagnolo L, Müller A, Karas M, Dingermann T, Marschalek R (2011). The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures. Leukemia 25, 135-144.

Balgobind BV, van den Heuvel-Eibrink MM, Menezes RX, Reinhardt D, Hollink IHIM, Peters STJCM, van Wering ER, Kaspers GJL, Cloos J, de Bont ESJM, Cayuela JM, Baruchel A, Meyer C, Marschalek R, Trka J, Stary J, Beverloo HB, Pieters R, Zwaan CM, den Boer  ML (2011). Evaluation of gene expression signatures predictive for cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Haematologica 96, 221-230.

Coenen EA, Zwaan CM, Meyer C, Marschalek R, Pieters R, Beverloo HB and van den Heuvel-Eibrink MM (2011). KIAA1524: a novel MLL translocation partner in AML. Leuk Res 35, 133-135.

2010

Cerveira N, Meyer C Santos J, Torres L, Lisboa S, Pinheiro M, Bizarro S, Correia C, Norton L, Marschalek R, Teixeira MR (2010). A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia. BMC Cancer 10, 518.

Balgobind BV, Zwaan CM, Reinhardt D, Arentsen-Peters TJCM, Hollink IHIM, de Haas V, Kaspers GJL, de Bont ESJM, Baruchel A, Stary J, Meyer C, Marschalek R, Creutzig U, Pieters R, Van den Heuvel-Eibrink MM (2010) High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome. Leukemia. 24, 2048-2055.

Alonso CN, Gallego MS, Rossi JG, Mansini AP, Rubio PL, Meyer C, Marschalek R, Felice MS (2010) BTBD18: A novel MLL partner gene in an infant with acute lymphoblastic leukemia and inv(11)(q13;q23). Leuk Res 34, e294-296.

Zuna J, Zaliova M, Muzikova K, Meyer C, Lizcova L, Zemanova Z, Votava F, Marschalek R, Stary J, Trka J (2010). Acute leukemias with ETV6/ABL1 (TEL/ABL) fusion: poor prognosis and prenatal origin. Genes Chrom Cancer 49, 873-884.

De Braekeleer E, Meyer C, Le Bris MJ, Douet-Guilbert N, Basinko A, Morel F, Berthou C, Marschalek R, Férec C, De Braekeleer M (2010). Identification of a MLL-MLLT4 fusion gene resulting from a t(6;11)(q27;q23) presenting as a del(11q) in a child with T-cell acute lymphoblastic leukemia. Leuk Lymphoma 51, 1570-1573.

Hutter C, Attarbaschi, Fischer S, Meyer C, Dworzak M, König M, Marschalek R, Mann G, Haas OA, Panzer-Grümayer ER (2010). Acute monocytic leukaemia originating from MLL-MLLT3-positive pre-B cells. Br J Haematol 150, 621-623.

Eberle I, Pless B, Jacobi M, Dingermann T, Marschalek R (2010). Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells. Nucl Acids Res 38, 5384-5395.

Cóser V, Meyer C, Basegio R, Menezes J, Marschalek R, Pombo-de-Oliveira MS (2010). Nebulette is the second member of the nebulin family fused to the MLL gene in infant leukemia. Cancer Genet Cytogenet 198, 151-154.

Marschalek R (2010). Mixed lineage leukemia: roles in human malignancies and potential therapy. FEBS J 277:1822-1831.

De Braekeleer E, Meyer C, Douet-Guilbert N, Morel F, Le Bris MJ, Berthou C, Arnaud B, Marschalek R, Férec C, De Braekeleer M (2010). Complex and cryptic chromosomal rearrangements involving the MLL gene in acute leukemia: a study of 7 patients and review of the literature. Blood Cell Mol Disease 44, 268-274.

Bursen A, Schwabe K, Rüster B, Henschler R, Ruthardt M, Dingermann T, Marschalek R (2010). The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4. Blood 115, 3570-3579.

Lee SG, Park TS, Wonc SC, Song J, Lee KA, Choi JR, Marschalek R, Meyer C (2010). Three-way translocation involving MLL, MLLT1, and a novel third partner, NRXN1, in a patient with acute lymphoblastic leukemia and t(2;19;11) (p12;p13.3;q23). Cancer Genet Cytogenet 197, 32-38.

2009

Röhrs S, Dirks WG, Meyer C, Marschalek R, Scherr M, Slany R, Wallace A, Drexler HG, Quentmeier H. (2009) Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia. Mol Cancer 8, 86.

Park TS, Lee S-G, Song J, Lee K-A, Kim J, Choi TL, Marschalek R, Meyer C (2009). CASP8AP2: A novel partner gene of MLL rearrangement with t(6;11)(q15;23) in acute myeloid leukemia. Cancer Genet Cytogenet 195, 94-95.

De Braekeleer  E, Douet-Guilbert N, Morel F, Le Bris MJ, Meyer C,  Marschalek R, Férec C, De Braekeleer M (2009). FLNA, a new partner gene fused to MLL in a patient with acute myelomonoblastic leukemia. Br J Haematol 146, 693-695.

Trentin L, Girodan M, Dingermann T, Basso G, te Kronnie G, Marschalek R (2009). Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients. Eur J Haematol 83(5):406-19.

Balgobind BV, Zwaan CM, Meyer C, Marschalek R, van Galen JF, van Drunen E, Pieters R, Beverloo HB, van den Heuvel-Eibrink M (2009). NRIP3: A novel translocation partner of MLL detected in a pediatric AML with complex chromosome 11 rearrangements. Haematologica. 94(7):1033.

Krauter J, Wagner K, Schäfer I, Marschalek R, Meyer C, Heil G, Schaich M, Ehninger G, Niederwieser D, Krahl R, Büchner T, Sauerland C, Schlegelberger B, Döhner K, Döhner H, Schlenk R, Ganser A (2009). Prognostic factors in adult patients up to 60 years with AML and translocations of chromosome band 11q23: Individual patient data based meta-analysis of the German AML-Intergroup. J Clin Oncology 27, 3000-3006.

Derwich K, Sedek L, Meyer C, Pieczonka A, Dawidowska M, Gaworczyk A, Wachowiak J, Konatkowska B, Witt M, Marschalek R, Szczepanski T (2009). Infant acute bilineal leukemia. Leuk Res 33, 1005-1008.

Meyer C and Marschalek R (2009). LDI-PCR: Identification of known and unknown gene fusions of the human MLL gene (book chapter). Methods Mol Biol 538,1-13.

Meyer C, Kowarz E, Hofmann J, Renneville A, Zuna J, Trka J, Ben Abdelali R, Macintyre E, De Braekeleer E, De Braekeleer M, Delabesse E, Pombo de Oliveira M, Cavé H, Clappier E, van Dongen JJM, Balgobind BV, van den Heuvel-Eibrink MM, Beverloo HB, Panzer-Grümayer R, Teigler-Schlegel A, Harbott J, Kjeldsen E, Schnittger S, Koehl U, Gruhn B, Heidenreich O, Chan LC, Yip SF, Krzywinski M, Eckert C, Möricke A, Schrappe M, Alonso CN, Schäfer BW, Krauter J, Lee DA, zur Stadt U, Te Kronnie G, Sutton R, Izraeli S, Trakhtenbrot L, Lo Nigro L, Tsaur G, Fechina L, Szczepanski T, Strehl S, Ilencikova D, Molkentin M, Burmeister T, Dingermann T, Klingebiel T, Marschalek R (2009). New Insights into the MLL recombinome of acute leukemias. Leukemia 23, 1490-1499.

De Braekeleer  E, Lanotto JC, Douet-Guilbert N, Meyer C, Le Bris MJ, Marschalek R, Berthou C, Férec C, De Braekeleer M (2009). A second case of secondary acute myeloblastic leukemia associated with the MLL-KIAA0284 fusion gene. Blood Cells Mol Dis 42, 292-293.

Van der Velden VH, Corral L, Valsecchi MG, Jansen MW, De Lorenzo P, Cazzaniga G, Panzer-Grümayer ER, Schrappe M, Schrauder A, Meyer C, Marschalek R, Nigro LL, Metzler M, Basso G, Mann G, Den Boer ML, Biondi A, Pieters R, Van Dongen JJ (2009). Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol. Leukemia 23,1073-1079.

Meyer C, Brieger A, Plotz G, Weber N, Passmann S, Dingermann T, Zeuzem S, Trojan J, Marschalek R. An Interstitial Deletion at 3p21.3 Results in the Genetic Fusion of MLH1 and ITGA9 in a Lynch Syndrome Family. Clin Cancer Res. 15, 762-769.

Burmeister T, Meyer C, Schwartz S, Hofmann J, Molkentin M, Hubert D, Schneider B, Raff T, Reinhardt R, Gökbuget N, Hoelzer D, Thiel E, Marschalek R. The MLL recombinome of adult acute lymphoblastic leukemia – results from the GMALL study group. Blood 113, 4011-4015.

De Braekeleer E, Meyer C, Douet-Guilbert N, Morel F, Le Bris M-J, Marschalek R, Férec C, De Braekeleer M. A COMPLEX 1;11;19 TRANSLOCATION INVOLVING THE MLL GENE IN A PATIENT WITH CONGENITAL ACUTE MONOBLASTIC LEUKEMIA IDENTIFIED BY MOLECULAR AND CYTOGENETIC TECHNIQUES. Ann Hematol 88, 795-797

Zuna J, Burjanivova T, Mejstrikova E, Zemanova Z, Muzikova K, Meyer C, Horsley SW, Kearney K, Colman S, Ptozskova H, Marschalek R, Hrusak O, Stary J, Greaves M, Trka J (2009). Covert pre-leukaemia driven by MLL gene fusion. Gene Chrom Cancer 48, 98-107.

2008

Zuna J, Burjanivova T, Mejstrikova E, Zemanova Z, Muzikova K, Meyer C, Horsley SW, Kearney L, Colman S, Ptoszkova H, Marschalek R, Hrusak O, Stary J, Greaves M, Trka J (2008). Covert preleukemia driven by MLL gene fusion. Gene ChromCancer. 48, 98-107.

Marschalek R (2008). Etoposide-treatment and MLL rearrangements. Eur J Haematol. [Epub ahead of print].

Mohl A, Marschalek R, Masszi T, Nagy E, Obser T, Oyen F, Sallai K, Bodó I, Schneppenheim R (2008). An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary. J Thromb Haemost. 6, 1729-35.

Burmeister T, Meyer C, Thiel G, Reinhardt R, Thiel E, Marschalek R (2008). A MLL-KIAA0284 fusion gene in a patient with secondary acute myeloid leukemia and t(11;14)(q23;q32). Blood Cells Mol Dis. 41, 210-214.

Soler G, Radford I, Meyer C, Marschalek R, Brouzes C, Ghez D, Romana S, Berger R (2008). MLL insertion with MLL-MLLT3 gene fusion in acute leukemia: case report and review of the literature. Cancer Genet Cytogenet. 183, 53-59.

Metzler M, Staege MS, Harder L, Mendelova D, Zuna J, Fronkova E, Meyer C, Flohr T, Bednarova D, Harbott J, Langer T, Gesk S, Trka J, Siebert R, Dingermann T, Marschalek R, Niemeyer C, Rascher W (2008). Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemia. Leukemia. 22, 1807-1811.

2007

Choi WT, Folsom MR, Azim MF, Meyer C, Kowarz E, Marschalek R, Timchenko NA, Naeem RC, Lee DA (2007). C/EBPbeta suppression by interruption of CUGBP1 resulting from a complex rearrangement of MLL. Cancer Genet Cytogenet. 177, 108-114.

Zuna J, Cavé  H, Eckert E, Szczepanski T, Meyer C, Mejstrikova E, Fronkova E, Muzikova K, Clappier E, Mendelova D, Boutard P, Schrauder A, Sterba J, Marschalek R, van Dongen JJM, Hrusak O, Stary J, Jan Trka J (2007). Childhood Secondary ALL after ALL Treatment. Leukemia 21, 1431-1435.

Kowarz E, Burmeister T, Nigro LL, Jansen MWJC, Delabesse E, Klingebiel T, Dingermann T, Meyer C, Marschalek R (2007). Complex MLL rearrangements in MLL•AF4+/AF4•MLL- leukemia patients conceal the presence of reciprocal MLL fusion genes. Leukemia 21, 1232-1238.

Schneppenheim R, Castaman G, Federici AB, Kreuz W, Marschalek R, Oldenburg J, Oyen F, Budde U (2007). A common 253 kb deletion involving VWF and TMEM16B in German and Italian patients with severe VWD type 3. J Thromb Haemost 5, 722-728

Jansen MWJC, Corral L, van der Velden VHJ, Panzer-Grümayer R, Schrappe M, Schrauder A, Marschalek R, Meyer C, den Boer ML, Hop WJC, Basso, G, Biondi A, Pieters R, van Dongen JJM (2007). Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia 21, 633-641.

Meyer C, Burmeister T, Strehl, Zach O, Schneider B, Haas OA, Klingebiel T, Dingermann T, Marschalek (2007). Spliced MLL fusions: a novel mechanism to generate functional chimaeric MLL•MLLT1 transcripts in t(11;19)(q23;p13.3) leukaemia. Leukemia 21, 588-590.

Gaussmann A, Wenger T, Eberle I, Bursen A, Bracharz S, Herr I, Dingermann T, Marschalek R. (2006). Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformation. Oncogene. 26; 3352-63.

Scharf S, Zech J, Bursen A, Schraets D, Oliver PL, Kliem S, Pfitzner E, Gillert E, Dingermann T, Marschalek, R. (2007). Transcription links to recombination: a gene-internal promoter coincides with the recombination hotspot II of the human MLL gene. Oncogene 26, 1361-137.

2006

Strehl S, Koenig M, Meyer C, Schneider B, Harbott J, Ulrich Jäger U, von Bergh A, Loncarevic I, Jarosova M, Schmidt H, Moore SDP, Marschalek R, Haas OA (2006). Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants. Genes Chrom Cancer 45, 1041-11049.

Meyer C, Kowarz E, Oehm C, Klingebiel T, Dingermann T, Marschalek R (2006). Genomic DNA of leukemia patients: target for clinical diagnosis of MLL rearrangements. Biotechnol J 1, 656-663.

Attarbaschi A, Mann G, König M, Steiner M, Strehl S, Schneider B, Schreiberhuber A, Borkhardt A, Marschalek R, Pickl W, Lion T, Gadner H, Haas OA, Dworzak M; on behalf of the BFM Cooperative Study Group (2006). MLL-involving translocations predominantly occur in CD10–/CDw65+/CD15+ childhood pro-B and pre-B acute lymphoblastic leukaemia (ALL). Clinical Cancer Res 12, 2988-2994.

Burjanivova T,  Madzo J, Muzikova K, Meyer C, Schneider B, Votava F, Marschalek R, Stary J, Trka J, Zuna J (2006). Prenatal origin of childhood AML occurs less frequently than in childhood ALL. BMC Cancer 6, 100

Meyer C, Schneider B, Jakob S, Strehl S, Schnittger S, Schoch C, Jansen MWJC, van Dongen JJM, den Boer ML, Pieters R, Ennas MG, Angelucci E, Koehl U, Greil J, Griesinger F, zur Stadt U, Eckert C, Szczepanski T, Niggli FK, Schäfer BW, Kempski H, Brady HJM, Trka J, Lo Nigro L, Biondi A, Delabesse E, Macintyre E, Stanulla M, Schrappe M, Haas OA, Burmeister T, Dingermann T, Klingebiel T, Marschalek R (2006). The MLL recombinome of acute leukemias. Leukemia 20, 777-784.

Burmeister T, Marschalek R, Schneider B, Meyer C, Gökbuget N, Schwartz S, Hoelzer D, Thiel E (2006). Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations. Leukemia 20, 451-457.

2005

Teuffel O, Betts DR, Thali M, Eberle D, Meyer C, Schneider B, Marschalek R, Trakhtenbrot L, Amariglio N, Niggli FK, Schäfer BW. (2005). Clonal expansion of a new MLL rearrangement in the absence of leukemia. Blood 105(10):4151-2.

Meyer C, Schneider B, Reichel M, Angermüller S, Strehl S, Schnittger S, Schoch C, Jansen, MJC, van Dongen JJ, Pieters R, Haas OA, Dingermann T, Klingebiel T, Marschalek R. (2005). A new diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc. Natl. Acad. Sci. USA 102, 449-454.

2004

Kracht T, Schrappe M, Strehl S, Reiter A, Elsner HA, Trka J, Cario G, Viehmann S, Harbott J, Borkhardt A, Metzler M, Langer T, Repp R, Marschalek R, Welte K, Haas OA, Stanulla M. (2004). NQO1 C609T polymorphism in distinct entities of paediatric haematological neoplasms. Hematologica .

Marschalek R, Klingebiel T. (2004). Akute Hochrisiko Leukaemie bei Kindern. Forschung Frankfurt 2/2004, 40-42.

Brosi A, Burghardt B, Fischer E, Sichler O, Marschalek R. (2004) Interaktionen mit P-Glycoprotein. PZ PRISMA 11(2), 133-139.

Bursen A, Moritz S, Gaussmann A, Dingermann T, Marschalek R. (2004). Interaction of AF4 wildtype and AF4•MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?. Oncogene 23(37), 6237-6249.

Boehden GS, Restle A, Marschalek R, Stocking C, Wiesmuller L. (2004). Recombination at chromosomal sequences involved in leukemogenic rearrangements is differentially regulated by p53. Carcinogenesis 25(8), 1305-1313.

2003

Muth A, Mosandl A, Bursen A, Marschalek R, Sewell AC, Bohles H. (2003). Multidimensional gas chromatography-mass spectrometry for tracer studies of fatty acid metabolism via stable isotopes in cultured human trophoblast cells. J Chromatogr B Analyt Technol Biomed Life Sci. 791, 235-244.

Schraets, D., Lehmann, T., Dingermann, Th. & Marschalek, R. (2003). MLL mediated transcriptional gene regulation investigated by gene expression profiling. Oncogene 22, 3655-3668

2002

König, M., Reichel, M., Marschalek, R., Haas, O.A., Strehl, S. (2002). A highly specific and sensitive FISH assay for the detection of t(4;11)(q21;q23) in acute leukemias. British Journal of Haematology 116, 758-764.

Peham, M., Panzer, S., Fasching, K., Haas, O.A., Fischer, S., Marschalek, R., Gadner, H., Panzer-Grümayer, E.R. (2002). Low frequency of clonotypic IG and TCR gene rearrangements in t(4;11) infant acute lymphoblastic leukemia. British Journal of Haematology 117, 315-321.

2001

Reichel, M., Gillert, E., Breitenlohner, Repp, R., Greil, J., Beck, J.D., Fey, G.H. & Marschalek, R. (2001) MRD-Meeting report: "Rapid isolation of chromosomal breakpoints from patient with t(4;11) acute lymphoblastic leukemia: implications for basic and clinical research". Leukemia 15, 286-288.

Von Berg, A., Gargallo, P., De Prijck, B., Vranckx, H., Marschalek, R., Larippa, I., Kluin, Ph., Schuuring, E. & Hagemeijer, A. (2001) Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5' MLL sequences in chromosome 4. A molecular cytogenetic study. Leukemia 15, 595-600.

Reichel, M., Gillert, E., Angermüller, S., Hensel, J.P, Heidel, F., Lode, M., Leis, T., Biondi, A., Haas, O.A., Strehl, S., Panzer-Grümayer, E.R., Griesinger, F., Beck, J.D., Greil, J., Fey, G.H., Uckun, F.M. & Marschalek, R. (2001). Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus chuildren and adults with t(4;11) ALL. Oncogene 20, 2900-2907.

Hensel, J.P., Gillert, E., Fey, G.H. & Marschalek, R. (2001). Breakpoints of t(4;11) translocations in the human MLL and AF4 genes in ALL patients are preferentially clustered outside of high-affinity matrix attachment regions. Journal of Cellular Biochemistry 82, 299-309.

Fasching, K., Panzer, S., Haas, O.A., Borkhardt, A., Marschalek, R., Griesinger, F. & Panzer-Grümayer, E.R. (2001). Presence of N Regions in the Clonotypic DJ Rearrangements of the Ig Heavy Chain Genes Indicate an Exquisitely Short Latency in t(4;11) Positive Infant Acute Lymphoblastic Leukemia. Blood 98, 2272-2274.

2000

Bode, J., Benham, C., Ernst, E., Knopp, A., Marschalek, R., Strick, R. & Strissel, P. (2000). Fatal Connections: When DNA Ends Meet on the Nuclear Matrix. Journal of Cellular Biochemistry, Supplement 35, 3-22.

Fasching, K., Panzer, S., Haas, O.A., Marschalek, R., Gadner, H., & Panzer-Grümayer, R. (2000). Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia. Blood 95, 2722-2724.

1999

Reichel, M., Hensel, J.P, Gillert, E., Breitenlohner, Repp, R., Greil, J., Beck, J.D., Fey, G.H. & Marschalek, R. (1999). Rapid isolation of chromosomal breakpoints from patient with t(4;11) acute lymphoblastic leukemia: implications for basic and clinical research. Cancer Res. 59, 3357-3362.

Gillert, E., Leis, T., Repp, R., Reichel, M., Hösch, A., Breitenlohner, I., Angermüller, S., Borkhardt, A., Harbott, J., Lampert, F., Griesinger, F., Greil, J., Fey, G.H. & Marschalek, R. (1999). A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells. Oncogene 18, 4663-4671.

1998

Schrell, U.M.H., Koch, U., Marschalek, R., Schrauzer, T., Anders, M., Adams, E. & Fahlbush. R. (1998). Formation of autocrine loops in human cerebral meningioma tissue by Leukemia inhibitor factor, interleukin-6 and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M. J. Neurosurg. 88, 541-548.

Reichel, M., Gillert, E., Nilson, I., Siegler, G., Greil, J., Fey, G.H. & Marschalek, R. (1998). Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): The damage-repair model of translocation. Oncogene 17, 3035-3044.

1997

Schrell, U.M.H., Rittig, M.G., Anders, M., Kiesewetter, F., Marschalek, R., Koch, U.H. & Fahlbusch, R. (1997). Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and meningioma transplants by inducing the apoptotic pathway. J. Neurosurgery 86, 845-852.

Schrell, U.M.H., Rittig, M.G., Anders, M., Koch, U.H., Marschalek, R., Kiesewetter, F. & Fahlbusch, R. (1997). Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in size of meningiomas in patients treated with hydroxyurea. J. Neurosurgery 86, 840-844.

Ennas, M.-G., Greim, R., Sorio, C., Nieddu, M., Hammel, M., Scarpa, A., Croce, C.M., Fey, G.H. & Marschalek, R. (1997). The ALL-1/MLL/ HRX antigen is predominantly localized in the nucleus of both resting and proliferating peripheral blood mononuclear cells. Cancer Res. 57, 2035-2041.

Nilson, I., Reichel, M., Ennas, M.-G., Greim, R., Knörr, C., Siegler, G., Greil, J., Fey, G.H. & Marschalek, R. (1997). The exon/intron structure of the human AF-4 gene, a member of the AF-4/LAF-4/FMR-2 gene family coding for a nuclear protein with structural alterations in acute leukemia. Brit. J. Haematol. 98, 157-169.

Marschalek, R., Nilson, I., Löchner, K., Greim, R., Siegler, G., Greil, J., Beck, J.D. & Fey, G.H. (1997). The structure of the human ALL-1/MLL/HRX gene. Invited Review in Leukemia and Lymphoma 27, 417-428.

Morrison, A., Marschalek, R., Dingermann, T. & Harwood, A.J. (1997). A novel, negative selectable marker for gene disruption in Dictyostelium. Gene 202, 171-176.

Schrell, U.M.H., Koch, U., Marschalek, R., Schrauzer, T., Anders, M., Adams, E. & Fahlbush. R. (1997). Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6 and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M. Neurosurg. Focus 2, Art. 7.

1996

Löchner, K., Siegler, G., Führer, M., Greil, J., Beck, J. D., Fey, G.H. & Marschalek, R. (1996). A specific deletion within the breakpoint cluster region of the ALL-1 gene is associated with acute lymphoblastic T-cell leukemias. Cancer Res. 56, 2171-2177.

Nilson, I., Löchner, K., Siegler, G., Greil, J., Beck, J.D., Fey, G.H. & Marschalek, R. (1996). The exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukemias. Brit. J. Haemotol. 93, 966-972.

Schrell, U.M., Nomikos, P., Schrauzer, T., Anders, M., Marschalek, R., Adams, E.F. & Fahlbusch, R. (1996). Hormonal dependency of cerebral meningiomas. Acta Neurochir. Suppl. (Wien) 65, 54-57.

Schrell, U.M.H., Rittig, M.G., Koch, U.H., Marschalek, R. & Anders, M. (1996). Hydroxyurea for treatment of unresectable meningiomas. The Lancet 348, 888-889.

1995

Marschalek, R., Greil, J., Löchner, K., Nilson, I., Siegler, G., Zweckbronner, I., Beck, J. D. & Fey, G.H. (1995). Molecular analysis of the chromosomal breakpoint and fusion transcripts in the acute lymphoblastic SEM cell line with chromosomal translocation t(4;11). Brit. J. Haematol. 90, 308-320.

Ripperger, J., Fritz, S., Richter, K., Dreier, B., Schneider, K., Löchner, K., Marschalek, R., Hocke, G., Lottspeich, F. & Fey, G.H. (1995). Isolation of two Interleukin-6 response element binding proteins from acute phase rat livers. Ann. N.Y. Acad. Sci. 762, 252-261.

1994

Schumann, G., Zündorf, I., Hofmann, J., Marschalek, R. & Dingermann, Th. (1994). Internally located and oppositely oriented polymerase II promoters direct convergent transcription of a LINE-like retroelement, the Dictyostelium repetitive element, from Dictyostelium discoideum. Mol. Cell. Biol. 14, 3074-3084.

Schumann, G., Zündorf, I., Schmidt, A., Marschalek, R. & Dingermann, Th. (1994). Characterization of transcripts from the Dictyostelium discoideum retrotransposable genetic element DRE. Pharmazie 49, 923-925.

Greil, J., Gramatzki, M., Burger, R., Marschalek, R., Peltner, M., Trautmann, U., Hansen-Hagge, T.E., Bartram, C.R., Fey, G.H., Stehr, K.

Beck, J. (1994). The acute lymphoblastic leukemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7. Brit. J. Haematol. 86, 275-283.

1993

Hoja, U., Hofmann, J., Marschalek, R. & Dingermann, Th. (1993). Nucleotide sequence of a Dictyostelium gene encoding a protein homologous to the yeast ribosomal protein S31. Biochem. Biophys. Res. Commun. 190, 134-139.

Hofmann, J., Winckler, T., Hanenkamp, A., Bukenberger M., Schumann, G., Marschalek, R. & Dingermann, Th. (1993). The Dictyostelium discoideum 5S rDNA is organized in the same transcriptional orientation as the other rDNAs. Biochem. Biophys. Res. Commun. 191, 558-564.

Marschalek, R., Hofmann, J., Schumann, G., Bach, M. & Dingermann, Th. (1993). Different organization of the tRNA-gene-associated repetitive element, DRE, in NC4-derived strains and in other wild-type Dictyostelium discoideum strains. Eur. J. Biochem. 217, 627-631.

Rizzuto, R., Sandona, D., Brini, M., Marschalek, R., Dingermann , Th. & Bisson, R. (1993). Structure of the promoter region of the gene encoding cytochrome-c oxidase subunit-V in Dictyostelium. Eur. J. Biochem. 211, 411-414.

1992

Marschalek, R., Hofmann, J., Schumann, G., Gösseringer R. & Dingermann, Th. (1992). Structure of DRE, a retrotransposable element which integrates with position-specificity upstream of Dictyostelium discoideum tRNA genes. Mol. Cell. Biol. 12, 229-239.

Dingermann, Th., Frank-Stoll, U., Werner, H., Wissmann, A., Hillen, W., Jaquet, M. & Marschalek, R. (1992). RNA polymerase III catalyzed transcription can be regulated in Saccharomyces cerevisiae by the bacterial tetracycline repressor-operator system. EMBO J. 11,1487-1492.

Dingermann, Th., Werner, H., Schütz, A., Zündorf, I., Nerke, K., Knecht, D. & Marschalek, R. (1992). Establishment of a system for conditional gene expression using an inducible tRNA suppressor gene. Mol. Cell. Biol. 12, 4038-4045.

Marschalek, R., Hofmann, J., Schumann, G. & Dingermann, Th. (1992). Two distinct subforms of the retrotransposable DRE element in NC4 strains of Dictyostelium discoideum. Nucl. Acids Res. 20, 6247-6252.

1991

Marschalek, R. & Dingermann, Th. (1991). Structure, Organization and Function of tranfer RNA genes from the cellular slime mold Dictyostelium discoideum. Review in 'Advances in Gene Technology' Vol 2, 1991, JAI Press Ltd. London, Editor Peter J. Greenaway , ISBN:1-55938-268-6.

Bukenberger, M., Marschalek, R., Wolfram Salzburger & Dingermann, Th. (1991). Nuclear factors which bind to Dictyostelium discoideum Transfer RNA genes. Curr. Genetics 20, 129-135.

Hofmann, J., Schumann, G., Borschet, G., Gösseringer, R., Bach, M., Bertling, W., Marschalek, R. & Dingermann, Th. (1991). Transfer RNA genes from Dictyostelium discoideum are frequently associated with repetitive elements and contain consensus boxes in their 5'- and 3'-flanking regions. J. Mol. Biol. 222, 537-552.

Gooley, A., Marschalek, R. & Williams, K. (1991). Size polymorphism due to changes in the number of O-glycosylated tandem repeats in the Dictyostelium discoideum Glycoprotein PsA. Biochem. Biophys. Res. Commun. 178, 1194-1201.

1990

Marschalek, R., Kalpaxis, D. & Dingermann, Th. (1990). Temperature sensitive synthesis of transfer RNAs in vivo in Saccharomyces cerevisiae. EMBO J. 9, 1253-1258.

Marschalek, R., Borschet, G. & Dingermann, Th. (1990). Genomic organization of the transposable element Tdd-3 from Dictyostelium discoideum. Nucl. Acids Res. 18, 5751-5757.

1989

Marschalek, R., Amon-Böhm, E., Stoerker, J., Klages, S., Fleckenstein, B. & Dingermann, Th. (1989). CMER, an RNA encoded by the human Cytomegalovirus is most likely transcribed by RNA polymerase III. Nucl. Acids Res. 17, 631-643.

Dingermann, Th., Brechner, Th., Marschalek, R., Amon-Böhm, E. & Welker, D. (1989). tRNAGlu(GAA) genes from the cellular slime mold Dictyostelium discoideum. DNA 8,193-204.

Marschalek, R., Brechner, Th., Amon-Böhm, E. & Dingermann, Th. (1989). tRNA genes: landmarks for integration of mobile genetic elements in Dictyostelium discoideum. Science 244,1493-1496.

1988

Marschalek, R. & Dingermann, Th. (1988). Identification of a protein factor binding to the 5'-flanking region of a tRNA gene and being involved in modulation of tRNA gene transcription in vivo in Saccharomyces cerevisiae. Nucl. Acids Res. 16, 6737-6752.

Dingermann, Th., Amon-Böhm, E., Bertling, W., Marschalek, R. & Nerke, K. (1988). The gene family of nonallelic tRNAVal(GUU) genes from the cellular slime mold Dictyostelium discoideum. Gene 73, 373-384.

1987

Dingermann, Th., Nerke, K. & Marschalek, R. (1987). Influence of different 5´-flanking sequences of tRNA genes on their in vivo transcription efficiencies. Eur. J. Biochem. 170, 217-224.

Dingermann, Th., Amon-Böhm, E., Bertling, W., Marschalek, R. & Nerke, K. (1987). Structure, genomic organization and developmental expression of members of a tRNAVal(GUU) gene family of the cellular slime mold Dictyostelium discoideum. Mol. Gen. Life Sci. Adv. 6, 152-159.